139 related articles for article (PubMed ID: 34771490)
1. Assessment of Radiation-Induced Optic Neuropathy in a Multi-Institutional Cohort of Chordoma and Chondrosarcoma Patients Treated with Proton Therapy.
Köthe A; Feuvret L; Weber DC; Safai S; Lomax AJ; Fattori G
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771490
[TBL] [Abstract][Full Text] [Related]
2. Radiation tolerance of the optic pathway in patients treated with proton and photon radiotherapy.
Li PC; Liebsch NJ; Niemierko A; Giantsoudi D; Lessell S; Fullerton BC; Adams J; Shih HA
Radiother Oncol; 2019 Feb; 131():112-119. PubMed ID: 30773177
[TBL] [Abstract][Full Text] [Related]
3. Radiation-induced optic neuropathy after pencil beam scanning proton therapy for skull-base and head and neck tumours.
Kountouri M; Pica A; Walser M; Albertini F; Bolsi A; Kliebsch U; Bachtiary B; Combescure C; Lomax AJ; Schneider R; Weber DC
Br J Radiol; 2020 Mar; 93(1107):20190028. PubMed ID: 31322969
[TBL] [Abstract][Full Text] [Related]
4. Combining Clinical and Dosimetric Features in a PBS Proton Therapy Cohort to Develop a NTCP Model for Radiation-Induced Optic Neuropathy.
Köthe A; van Luijk P; Safai S; Kountouri M; Lomax AJ; Weber DC; Fattori G
Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):587-595. PubMed ID: 33421557
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of proton beam therapy for chordoma and chondrosarcoma of the skull base.
Fuji H; Nakasu Y; Ishida Y; Horiguchi S; Mitsuya K; Kashiwagi H; Murayama S
Skull Base; 2011 May; 21(3):201-6. PubMed ID: 22451826
[TBL] [Abstract][Full Text] [Related]
6. Vision loss following high-dose proton-based radiotherapy for skull-base chordoma and chondrosarcoma.
De Leo AN; Holtzman AL; Ho MW; Morris CG; Rutenberg MS; Rotondo RL; Bates JE; Indelicato DJ; Rao D; Asa Hasan M; Mendenhall WM
Radiother Oncol; 2021 May; 158():125-130. PubMed ID: 33610625
[TBL] [Abstract][Full Text] [Related]
7. Long term outcomes of patients with skull-base low-grade chondrosarcoma and chordoma patients treated with pencil beam scanning proton therapy.
Weber DC; Malyapa R; Albertini F; Bolsi A; Kliebsch U; Walser M; Pica A; Combescure C; Lomax AJ; Schneider R
Radiother Oncol; 2016 Jul; 120(1):169-74. PubMed ID: 27247057
[TBL] [Abstract][Full Text] [Related]
8. Results of spot-scanning proton radiation therapy for chordoma and chondrosarcoma of the skull base: the Paul Scherrer Institut experience.
Weber DC; Rutz HP; Pedroni ES; Bolsi A; Timmermann B; Verwey J; Lomax AJ; Goitein G
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):401-9. PubMed ID: 16168833
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric analysis of local failures in skull-base chordoma and chondrosarcoma following pencil beam scanning proton therapy.
Basler L; Poel R; Schröder C; Bolsi A; Lomax A; Tanadini-Lang S; Guckenberger M; Weber DC
Radiat Oncol; 2020 Nov; 15(1):266. PubMed ID: 33198810
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes and prognostic factors of skull-base chondrosarcoma patients treated with pencil-beam scanning proton therapy at the Paul Scherrer Institute.
Weber DC; Badiyan S; Malyapa R; Albertini F; Bolsi A; Lomax AJ; Schneider R
Neuro Oncol; 2016 Feb; 18(2):236-43. PubMed ID: 26323608
[TBL] [Abstract][Full Text] [Related]
11. Radiation induced optic neuropathy: Does treatment modality influence the risk?
Mohamed Ali A; Mathis T; Bensadoun RJ; Thariat J
Bull Cancer; 2019 Dec; 106(12):1160-1176. PubMed ID: 31757405
[TBL] [Abstract][Full Text] [Related]
12. The preliminary results of proton and carbon ion therapy for chordoma and chondrosarcoma of the skull base and cervical spine.
Guan X; Gao J; Hu J; Hu W; Yang J; Qiu X; Hu C; Kong L; Lu JJ
Radiat Oncol; 2019 Nov; 14(1):206. PubMed ID: 31752953
[TBL] [Abstract][Full Text] [Related]
13. The role of dose escalation and proton therapy in perioperative or definitive treatment of chondrosarcoma and chordoma: An analysis of the National Cancer Data Base.
Palm RF; Oliver DE; Yang GQ; Abuodeh Y; Naghavi AO; Johnstone PAS
Cancer; 2019 Feb; 125(4):642-651. PubMed ID: 30644538
[TBL] [Abstract][Full Text] [Related]
14. Challenges in linear accelerator radiotherapy for chordomas and chondrosarcomas of the skull base: focus on complications.
Hauptman JS; Barkhoudarian G; Safaee M; Gorgulho A; Tenn S; Agazaryan N; Selch M; De Salles AA
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):542-51. PubMed ID: 22137019
[TBL] [Abstract][Full Text] [Related]
15. Spot scanning proton therapy for malignancies of the base of skull: treatment planning, acute toxicities, and preliminary clinical outcomes.
Grosshans DR; Zhu XR; Melancon A; Allen PK; Poenisch F; Palmer M; McAleer MF; McGovern SL; Gillin M; DeMonte F; Chang EL; Brown PD; Mahajan A
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):540-6. PubMed ID: 25304948
[TBL] [Abstract][Full Text] [Related]
16. Hypofractionated stereotactic radiation therapy for skull base and upper cervical chordoma and chondrosarcoma: preliminary results.
Gwak HS; Yoo HJ; Youn SM; Chang U; Lee DH; Yoo SY; Rhee CH
Stereotact Funct Neurosurg; 2005; 83(5-6):233-43. PubMed ID: 16601376
[TBL] [Abstract][Full Text] [Related]
17. Does the SORG Algorithm Predict 5-year Survival in Patients with Chondrosarcoma? An External Validation.
Bongers MER; Thio QCBS; Karhade AV; Stor ML; Raskin KA; Lozano Calderon SA; DeLaney TF; Ferrone ML; Schwab JH
Clin Orthop Relat Res; 2019 Oct; 477(10):2296-2303. PubMed ID: 31107338
[TBL] [Abstract][Full Text] [Related]
18. Radiation-induced optic neuropathy following external beam radiation therapy for nasopharyngeal carcinoma: A retrospective case-control study.
Wang W; Yang H; Guo L; Su H; Wei S; Zhang X
Mol Clin Oncol; 2016 May; 4(5):868-872. PubMed ID: 27123298
[TBL] [Abstract][Full Text] [Related]
19. Locally challenging osteo- and chondrogenic tumors of the axial skeleton: results of combined proton and photon radiation therapy using three-dimensional treatment planning.
Hug EB; Fitzek MM; Liebsch NJ; Munzenrider JE
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):467-76. PubMed ID: 7852108
[TBL] [Abstract][Full Text] [Related]
20. Factors Associated with Occurrence of Radiation-induced Optic Neuropathy at "Safe" Radiation Dosage.
Doroslovački P; Tamhankar MA; Liu GT; Shindler KS; Ying GS; Alonso-Basanta M
Semin Ophthalmol; 2018; 33(4):581-588. PubMed ID: 28704158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
